Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1251 - 1258 of 1258

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1301 - 1325 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
CADTH Pharmaceutical Reviews Update — Issue 12		Jan 9, 2020	Reimbursement Review	Pharmaceutical Review Update
insulin glargine	media:document:0b3ee957-8a86-4568-8d07-a64126d35ae1	Jan 7, 2020	Reimbursement Review		Withdrawn	SE0589-000
Lynparza for Newly Diagnosed Ovarian Cancer – Details	OlaparibLynparza_NewlyDiagnosedOC10174ProvFunding.pdf 10174OlaparibOC_fnRec_2019-12-04_ChairApproved_Post_05Dec2019_final.pdf 10174OlaparibOC_fnEGR_NOREDACT-ABBREV_Post_05Dec2019_final.pdf 10174OlaparibOC_fnCGR_NOREDACT_Post_05Dec2019_final.pdf 10174OlaparibOC_inRec_2019-10-03_Post_03Oct2019_final.pdf 10174OlaparibOC_PAGFeedbackSummary_2019-10-11_Post_05Dec2019_final.pdf 10174OlaparibOC_SponsorFeedback_2019-10-18_Post_05Dec2019_final.pdf 10174OlaparibOC_PatientFeedback_OCC_2019-10-16_Post_05Dec2019_final.pdf 10174OlaparibOC_ClinicianFeedback_CCO_2019-10-18_Post_05Dec2019_final.pdf 10174OlaparibOC_PatientInput_COI_2019-05-03_Post_05Dec2019_final_Redacted.pdf 10174OlaparibOC_Combined COIs_Post_05Dec2019_final_Redacted.pdf	Dec 20, 2019	Reimbursement Review		Complete	PC0174-000
Nerlynx for Hormone Receptor-Positive Breast Cancer – Details	NeratinibNerlynx_BreastCancer10172ProvFunding.pdf 10172NeratinibEBC_fnRec_Chair Approved_Post_05Dec2019_final.pdf 10172NeratinibEBC_inEGR_NOREDACT-ABBREV_Post_05Dec2019_final.pdf 10172NeratinibEBC_fnCGR_NOREDACT_Post_05Dec2019_final.pdf 10172NeratinibEBC_inRec_1 Oct 2019_Post_03Oct2019_final.pdf 10172NeratinibEBC_PAGFeedbackSummary_2019-10-11_Post_05Dec2019_final_Redacted.pdf 10172NeratinibEBC_SponsorFeedback_2019-10-18_Post_05Dec2019_final_Redacted.pdf 10172NeratinibEBC_PatientFeedback_Combined_Post_05Dec2019_final_Redacted.pdf 10172NeratinibEBC_ClinicianFeedback_CCO_2019-10-18_Post_05Dec2019_final_Redacted.pdf 10172NeratinibEBC_Combined Patient_COI_Post_05Dec2019_final_Redacted.pdf 10172NeratinibEBC_Combined_Clinician COIs_Post_05Dec2019_final_Redacted.pdf	Dec 20, 2019	Reimbursement Review		Complete	PC0172-000
Drug Therapies for the Long-Term Prophylaxis of Hereditary Angioedema Attacks	ob0007-hae-prophylaxis-redacted.pdf	Dec 19, 2019	Health Technology Review		Completed	OB0007-000
Trifluridine and Tipiracil (Lonsurf) for Metastatic Colorectal Cancer Resubmission – Details	pcodr_provfund-10173-trifluridine-tipiracil_lonsurf_mcrc.pdf 10173Trifluridine-TipiracilmCRC_fnrec_Chair Approved_Post_29Aug2019_revised_final.pdf 10173Trifluridine-TipiracilmCRC_fnEGR_NOREDACT-ABBREV_Post_29Aug2019_final.pdf 10173Trifluridine-TipiracilmCRC_fnCGR_NOREDACT_Post_29Aug2019_final.pdf 10173Trifluridine-TipiracilmCRC_inRec_Chair approved_NOREDACT_Post_05Jul2019_final.pdf 10173Trifluridine-TipiracilmCRC_PAGFeedbackSummary_FINAL_2019-07-15_Post_29Aug2019_final.pdf 10173Trifluridine-TipiracilmCRC_SubmitterFeedback_2019-07-19_Post_29Aug2019_final.pdf 10173Trifluridine-TipiracilmCRC_PatientFeedback_CCC_2019-07-19_Post_29Aug2019_final.pdf 10173Trifluridine-TipiracilmCRC_ClinicianFeedback_Ko_2019-07-19_Post_29Aug2019_final.pdf 10173Trifluridine-TipiracilmCRC_Patient COIs_Post_29Aug2019_final_Redacted.pdf 10173Trifluridine-TipiracilmCRC_Clinicians COIs_Post_29Aug2019_final_Redacted.pdf	Dec 19, 2019	Reimbursement Review		Complete	PC0173-000
Pilocarpine for Medication-induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1225 Pilocarpine for MIX Final.pdf	Dec 11, 2019	Health Technology Review	Summary with Critical Appraisal		RC1225-000
Inclisiran: A Small Interfering RNA Molecule for Treating Hypercholesterolemia		Dec 9, 2019	Horizon Scan	Emerging Health Technologies	Completed	EH0076-000
Screening and Treatment of Obstetric Anemia: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1216 - Screening and treatment of obstetric anemia Final.pdf	Dec 6, 2019	Health Technology Review	Summary with Critical Appraisal	Completed	RC1216-000
CADTH Pharmaceutical Reviews Update — Issue 11		Nov 21, 2019	Reimbursement Review	Pharmaceutical Review Update
Biopsy for Adults with Suspected Skin Cancer: A Rapid Qualitative Review	Biopsy for Adults with Suspected Skin Cancer: A Rapid Qualitative Review	Nov 21, 2019	Health Technology Review	Rapid Review	Completed	RC1215-000
Dosing and Timing of Immuno-Oncology Drugs	ho0008-dosing-timing-immuno-oncology-drugs.pdf	Nov 21, 2019	Health Technology Review	Technology Review	Completed	HO0008-000
Larotrectinib for Neurotrophic Tyrosine Receptor Kinase (NTRK) Locally Advanced or Metastatic Solid Tumours – Details	LarotrectinibVitrakvi_NTRKLocallyAdvancedorMetastaticSolidTumours10159ProvFunding.pdf 10159LarotrectinibNTRK+SolidTumours_fnRec_REDACT_31Oct201_ChairApproved_final.pdf 10159LarotrectinibNTRK+SolidTumours_fnEGR_NOREDACT-ABBREV_Post_31Oct2019_final.pdf 10159LarotrectinibNTRK+SolidTumours_fnCGR_REDACT_Post_31Oct2019_final.pdf 10159LarotrectinibNTRK+SolidTumours_inRec_2019-08-27_ChairApproval_REDACT_Post_29Aug2019_final.pdf 10159LarotrectinibNTRK+SolidTumours_PAGFeedbackSummary_FINAL_Post_31Oct2019_final.pdf 10159LarotrectinibNTRK+SolidTumours_SponsorFeedback_2019-09-19_Post_31Oct2019_final.pdf 10159LarotrectinibNTRK+SolidTumours_PtFeedback_Combined_Post_31Oct2019_final.pdf 10159LarotrectinibNTRK+SolidTumours_Combined_ClinicianF-B_Post_31Oct2019_final.pdf 10159LarotrectinibNTRK+SolidTumours_Combined_COI_Post_31Oct2019_final_Redacted.pdf 10159LarotrectinibNTRK+SolidTumours_Clombined COI_Post_31Oct2019_final_Redacted.pdf	Nov 15, 2019	Reimbursement Review		Complete	PC0159-000
Idhifa for Acute Myeloid Leukemia – Details	EnasidenibIdhifa_AML10144ProvFunding.pdf 10144EnasidenibAML_fnRec_ApprovedbyChair_Post_31Oct2019_final.pdf 10144EnasidenibAML_fnEGR_NOREDACT-ABBREV_Post_31Oct2019_final.pdf 10144EnasidenibAML_fnCGR_NOREDACT_Post_31Oct2019_final.pdf 10144EnasidenibAML_inRec_approvedbyChair_NOREDACT_Post_29Aug2019_final.pdf 10144EnasidenibAML_PAGFeedbackSummary_FINAL_Post_31Oct2019_final.pdf 10144EnasidenibAML_SponsorFeedback_2019-09-19_revised_Post_31Oct2019_final.pdf 10144EnasidenibAML_PatientFeedback_LLSC_2019-09-26_FINAL_Post_31Oct2019_final.pdf 10144EnasidenibAML_ClinicianFeedback_CCO_2019-09-11_Post_31Oct2019_final.pdf 10144EnasidenibAML_PatientInput_LLSC_COI_Post_31Oct2019_final.pdf 10144EnasidenibAML_Clinician_Combined_COI_Post_31Oct2019_final_Redacted.pdf	Nov 15, 2019	Reimbursement Review		Complete	PC0144-000
Prostatectomy for People with Prostate Cancer: A Rapid Qualitative Review	Prostatectomy for People with Prostate Cancer: A Rapid Qualitative Review	Nov 12, 2019	Health Technology Review	Summary with Critical Appraisal	Completed	RC1209-000
Genome-Wide Sequencing: Ethical Considerations	he0020-genonme-wide-sequencing-protocol.pdf he0020-genome-wide-sequencing-ethical-considerations.pdf	Nov 12, 2019	Health Technology Review	Technology Review	Completed	HE0020-000
Health Technology Update - Issue 25		Nov 11, 2019	Horizon Scan		Completed	EN0015-000
benralizumab	sf0592-fasenra-request-for-advice.pdf sf0592-fasenra-patient-input.pdf sf0592-fasenra-cdec-rec-march-29-19.pdf	Nov 6, 2019	Reimbursement Review		Complete	SF0592-000
mepolizumab	sf0593-nucala-request-for-advice.pdf sf0593-nucala-patient-input.pdf sf0593-nucala-cdec-rec-march-29-19.pdf	Nov 6, 2019	Reimbursement Review		Complete	SF0593-000
ulipristal acetate	SF0609 Fibristal - Group Patient Input June 28, 2019.pdf SF0609 Fibristal RfA - CDEC Final Recommendation July 30, 2019_for posting.pdf sf0609-fibristal-request-for-advice-clinical-review-report.pdf	Nov 6, 2019	Reimbursement Review		Complete	SF0609-000
ulipristal acetate	SF0528_Fibristal_RFA_complete_Nov_22_17.pdf SF0528_Fibristal_RFA_Report.pdf SF0528_Fibristal_PI_Submissions.pdf	Nov 6, 2019	Reimbursement Review		Complete	SF0528-000
reslizumab	sf0591-cinqair-request-for-advice.pdf sf0591-cinqair-patient-input.pdf sf0591-cinqair-cdec-rec-march-29-19.pdf	Nov 6, 2019	Reimbursement Review		Complete	SF0591-000
pegfilgrastim	se0588-fulphila-biosimilar-dossier.pdf	Nov 6, 2019	Reimbursement Review		Complete	SE0588-000
Pegfilgrastim	SE0555_lapelga_biosimilar_dossier.pdf	Nov 6, 2019	Reimbursement Review		Complete	SE0555-000
infliximab	TS0001-PsO-Updated-Streamlined-Rec.pdf SE0532 Renflexis - CDEC Final Recommendation February 20, 2018(redacted)_for posting.pdf SE0532_Renflexis_Combined_Report.pdf SE0532_Renflexis_PI.pdf	Nov 6, 2019	Reimbursement Review		Complete	SE0532-000